Role of excess volume in the pathophysiology of hypertension in chronic kidney disease

Kidney International

Volumn 64, Issue 5, 2003, Pages 1772-1779

  Vasavada, Nina ^b   Agarwal, Rajiv ^a  

^a RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Brain natriuretic peptide; Chronic renal failure; Diuretics; Electrical impedance; Furosemide; Plasma aldosterone; Plasma renin activity; Randomized controlled trial; Torsemide

Indexed keywords

ALDOSTERONE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; FUROSEMIDE; LOOP DIURETIC AGENT; RENIN; TORASEMIDE; WATER;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; BIOPHYSICS; BLOOD PRESSURE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; EXTRACELLULAR SPACE; HORMONE DETERMINATION; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TOTAL BODY WATER; TREATMENT OUTCOME;

EID: 0142249392     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00273.x     Document Type: Article

References (32)

1. THE ALLHAT OFFICERS AND COORDINATORS FOR THE ALLHAT COLLABORATIVE RESEARCH GROUP: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288:2981-2997, 2002
2. JONES CA, MCQUILLAN GM, KUSEK JW, et al: Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 32:992-999, 1998
3. BUCKALEW VM, JR, BERG RL, WANG SR, et al: Prevalence of hypertension in 1,795 subjects with chronic renal disease: The Modification of Diet in Renal Disease Study baseline cohort. Modification of Diet in Renal Disease Study Group. Am J Kidney Dis 28:811-821, 1996
4. VASAVADA N, SAHA C, AGARWAL R: A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease. Kidney Int 64:632-640, 2003
5. AGARWAL R, VASAVADA N, CHASE SD: High-performance liquid chromatography for iothalamate in biological samples. J Chromatogr B Analyt Technol Blamed Life Sci 785:345-352, 2002
6. MOLLOY TJ, OKIN PM, DEVEREUX RB, KLIGFIELD P: Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product. J Am Coll Cardiol 20:1180-1186, 1992
7. KOOMANS HA, ROOS JC, DORHOUT MEES EJ, DELAWI IM: Sodium balance in renal failure. A comparison of patients with normal subjects under extremes of sodium intake. Hypertens 7:714-721, 1985
8. KOOMANS HA, GEERS AB, BOER P, et al: A study on the distribution of body fluids after rapid saline expansion in normal subjects and in patients with renal insufficiency: Preferential intravascular deposition in renal failure. Clin Sci Lond 64:153-160, 1983
9. ZILLIKENS MC, VAN DEN BERG JW, WILSON JH, SWART GR: Whole-body and segmental bioelectrical-impedance analysis in patients with cirrhosis of the liver: Changes after treatment of ascites. Am J Clin Nutr 55:621-625, 1992
10. CORSINI WA, HOOK JB, BAILIE MD: Control of renin secretion in the dog. Effects of furosemide on the vascular and macula densa receptors. Circ Res 37:464-470, 1975
11. FERNANDEZ PG, ZACHARIAH PK, GAULT MH, BRYANT DG: Peripheral renin activity before and after furosemide in normotensives and hypertensives. Clin Invest Med 3:253-258, 1980
12. PRATT JH: Role of angiotensin II in potassium-mediated stimulation of aldosterone secretion in the dog. J Clin Invest 70:667-672, 1982
13. TOTSUNE K, TAKAHASHI K, SATOH F, et al: Urinary immunoreactive brain natriuretic peptide in patients with renal disease. Regul Pept 63:141-147, 1996
14. VOGT-SCHADEN M, GAGELMANN M, HOCK D, et al: Degradation of porcine brain natriuretic peptide (pBNP-26) by endoprotease-24.11 from kidney cortical membranes. Biochem Biophys Res Commun 161:1177-1183, 1989
15. WILCOX JN, AUGUSTINE A, GOEDDEL DV, LOWE DG: Differential regional expression of three natriuretic peptide receptor genes within primate tissues. Mol Cell Biol 11:3454-3462, 1991
16. ALMIREZ R, PROTTER AA: Clearance of human brain natriuretic peptide in rabbits; effect of the kidney, the natriuretic peptide clearance receptor, and peptidase activity. J Pharmacol Exp Ther 289:976-980, 1999
17. KOOMANS HA, ROOS JC, BOER P, et al: Salt sensitivity of blood pressure in chronic renal failure. Evidence for renal control of body fluid distribution in man. Hypertension 4:190-197, 1982
18. CONWAY J, LAUWERS P: Hemodynamic and hypotensive effects of long-term therapy with chlorothiazide. Circulation 21:21-27, 1960
19. VARDAN S, MOOKHERJEE S, WARNER R, SMULYAN H: Systolic hypertension in the elderly. Hemodynamic response to long-term thiazide diuretic therapy and its side effects. JAMA 250:2807-2813, 1983
20. WILSON IM, FREIS ED: Relationship between plasma and extracellular fluid volume depletion and the antihypertensive effect of chlorothiazide. Circulation 20:1028-1036, 1959
21. LETH A: Changes in plasma and extracellular fluid volumes in patients with essential hypertension during long-term treatment with hydrochlorothiazide. Circulation 42:479-485, 1970
22. VAN BRUMMELEN P, SCHALEKAMP MA: Body fluid volumes and the response of renin and aldosterone to short- and long-term thiazide therapy of essential hypertension. Acta Med Scand 207:259-264, 1980
23. RAM CV, GARRETT BN, KAPLAN NM: Moderate sodium restriction and various diuretics in the treatment of hypertension. Arch Intern Med 141:1015-1019, 1981
24. WINER BM: The antihypertensive mechanisms of salt depletion induced by hydrochlorothiazide. Circulation 24:788-796, 1961
25. ALEKSANDROW D, WYSZNACKA W, GAJEWSKI J: Influence of chlorothiazide upon arterial responsiveness to norepinephrine in hypertensive subjects. N Engl J Med 261:1052-1055, 1959
26. VAN BRUMMELEN P, SCHALEKAMP MA: Body fluid volumes and the response of renin and aldosterone to short- and long-term thiazide therapy of essential hypertension. Acta Med Scand 207:259-264, 1980
27. MUNIZ P, FORTUNO A, ZALBA G, et al: Effects of loop diuretics on angiotensin II-stimulated vascular smooth muscle cell growth. Nephrol Dial Transplant 16(Suppl 1):14-17, 2001
28. LUFT FC: Torasemide in the treatment of arterial hypertension. J Cardiovasc Pharmacol 22(Suppl 3):S32-S39, 1993
29. SPANNBRUCKER N, ACHHAMMER I, METZ P, GLOCKE M: Comparative study on the antihypertensive efficacy of torasemide and indapamide in patients with essential hypertension. Arzneimittelforschung 38:190-193, 1988
30. LEONETTI G, TERZOLI L, SALA C, et al: Relationship between the hypotensive and renin-stimulating actions of diuretic therapy in hypertensive patients. Clin Sci Mol Med (Suppl 4):307s-309s, 1978
31. VAUGHAN ED, JR, CAREY RM, PEACH MJ, et al: The renin response to diuretic therapy: A limitation of antihypertensive potential. Circ Res 42:376-381, 1978
32. GRAUDAL NA, GALLOE AM, GARRED P: Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: A meta-analysis. JAMA 279:1383-1391, 1998